Home/Filings/4/0001144204-14-068927
4//SEC Filing

CASI Pharmaceuticals, Inc. 4

Accession 0001144204-14-068927

CIK 0000895051operating

Filed

Nov 13, 7:00 PM ET

Accepted

Nov 14, 5:04 PM ET

Size

7.7 KB

Accession

0001144204-14-068927

Insider Transaction Report

Form 4
Period: 2014-09-17
Wong Cynthia
COO & General Counsel
Transactions
  • Award

    Stock Options (Right to Buy)

    2014-04-03+100,000100,000 total
    Exercise: $1.84Exp: 2024-04-03Common Stock (100,000 underlying)
  • Award

    Stock Options (Right to Buy)

    2012-08-15+50,00050,000 total
    Exercise: $1.99Exp: 2022-08-15Common Stock (50,000 underlying)
Footnotes (1)
  • [F1]The stock options vested as a result of the reported license transaction with Spectrum Pharmaceuticals, Inc. on September 17, 2014.

Issuer

CASI Pharmaceuticals, Inc.

CIK 0000895051

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000895051

Filing Metadata

Form type
4
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 5:04 PM ET
Size
7.7 KB